摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

<3-(4-acetylphenyl)-2-oxo-5-oxazolidinyl>methyl methanesulfonate | 139225-43-7

中文名称
——
中文别名
——
英文名称
<3-(4-acetylphenyl)-2-oxo-5-oxazolidinyl>methyl methanesulfonate
英文别名
[3-(4-Acetylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl methanesulfonate
<3-(4-acetylphenyl)-2-oxo-5-oxazolidinyl>methyl methanesulfonate化学式
CAS
139225-43-7
化学式
C13H15NO6S
mdl
——
分子量
313.331
InChiKey
KJHOTPWRGIXNDA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    533.0±33.0 °C(Predicted)
  • 密度:
    1.374±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    21
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    98.4
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The B group
    摘要:
    The synthesis and structure/activity studies of the effect of varying the "B" group in a series of oxazolidinone antibacterials (I) are described. Two synthetic routes were used: (1) alkylation of aniline with glycidol followed by dialkyl carbonate heterocyclization to afford I (A = H, B = OH), whose arene ring was further elaborated by using electrophilic aromatic substitution methodology; (2) cycloaddition of substituted aryl isocyanates with epoxides to give A and B with a variety of values. I with B = OH or Br were converted to other "B" functionalities by using SN2 methodology. Antibacterial evaluation of compounds I with A = acetyl, isopropyl, methylthio, methylsulfinyl, methylsulfonyl, and sulfonamido and a variety of different "B" groups against Staphylococcus aureus and Enterococcus faecalis concluded that the compounds with B = aminoacyl, and particularly acetamido, were the most active of those examined in each A series, possessing MICs in the range of 0.5-4 micrograms/mL for the most active compounds described.
    DOI:
    10.1021/jm00128a003
  • 作为产物:
    参考文献:
    名称:
    Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The B group
    摘要:
    The synthesis and structure/activity studies of the effect of varying the "B" group in a series of oxazolidinone antibacterials (I) are described. Two synthetic routes were used: (1) alkylation of aniline with glycidol followed by dialkyl carbonate heterocyclization to afford I (A = H, B = OH), whose arene ring was further elaborated by using electrophilic aromatic substitution methodology; (2) cycloaddition of substituted aryl isocyanates with epoxides to give A and B with a variety of values. I with B = OH or Br were converted to other "B" functionalities by using SN2 methodology. Antibacterial evaluation of compounds I with A = acetyl, isopropyl, methylthio, methylsulfinyl, methylsulfonyl, and sulfonamido and a variety of different "B" groups against Staphylococcus aureus and Enterococcus faecalis concluded that the compounds with B = aminoacyl, and particularly acetamido, were the most active of those examined in each A series, possessing MICs in the range of 0.5-4 micrograms/mL for the most active compounds described.
    DOI:
    10.1021/jm00128a003
点击查看最新优质反应信息

文献信息

  • Synthesis and antibacterial activity of isothiazolyl oxazolidinones and analogous 3(2H)-isothiazolones
    作者:Neda Adibpour、Ali Khalaj、Saeed Rajabalian
    DOI:10.1016/j.ejmech.2009.09.019
    日期:2010.1
    The synthesis and antibacterial activity of several new 5-((3-oxoisothiazol-2(3H)-yl)methyl)-3-phenyloxazolidin-2-ones 8 and analogous 2-(4-substituted phenyl)-3(2H)-isothiazolones 3 and 4 substituted at 4 and/or 3-positions of the phenyl moiety with different groups of which some have shown to increase the antibacterial activity of both 3-aryl-2-oxazolidinones and 3(2H)-isothiazolones is described
    几种新的5-((3-oxoisothiazol-2(3H)-yl)methyl)-3-phenyloxazolidin-2-ones 8和类似的2-(4-取代苯基)-3(2H)-的合成及抗菌活性描述了在苯基部分的4和/或3位被不同基团取代的异噻唑酮3和4,其中一些已显示出增加3-芳基-2-恶唑烷酮和3(2H)-异噻唑酮的抗菌活性。活性最高的化合物是异噻唑基恶唑烷酮8a,未取代的j和8b具有4-F取代苯环的化合物,对某​​些测试的微生物显示出比类似的3(2H)-异噻唑酮更高的活性,并且与利奈唑胺,万古霉素和环丙沙星具有可比或更高的活性。F的位置变化和/或使用较大的取代基使化合物的活性降低或没有活性。对小鼠成纤维细胞(NIH / 3T3)细胞的细胞毒性评估表明,这些化合物在非细胞毒性浓度下具有抗菌活性。
  • Oxazolidinone mit ZNS-dämpfender Wirkung
    申请人:MERCK PATENT GmbH
    公开号:EP0459256A1
    公开(公告)日:1991-12-04
    Neue Oxazolidinone der Formel I worin R¹, R², R³, R⁴, Z und n die in Patentanspruch 1 angegebene Bedeutung haben, sowie deren Salze zeigen das Zentralnervensystem beeinflussende, insbesondere dämpfende Wirkungen.
    式 I 的新噁唑烷酮 其中 R¹、R²、R³、R⁴、Z 和 n 如权利要求 1 所定义、 及其盐类 对中枢神经系统有影响,特别是有减弱作用。
  • US5232931A
    申请人:——
    公开号:US5232931A
    公开(公告)日:1993-08-03
  • Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The B group
    作者:Walter A. Gregory、David R. Brittelli、C. L. J. Wang、Mark A. Wuonola、Ronald J. McRipley、David C. Eustice、Virginia S. Eberly、Andrew M. Slee、Martin Forbes、P. T. Bartholomew
    DOI:10.1021/jm00128a003
    日期:1989.8
    The synthesis and structure/activity studies of the effect of varying the "B" group in a series of oxazolidinone antibacterials (I) are described. Two synthetic routes were used: (1) alkylation of aniline with glycidol followed by dialkyl carbonate heterocyclization to afford I (A = H, B = OH), whose arene ring was further elaborated by using electrophilic aromatic substitution methodology; (2) cycloaddition of substituted aryl isocyanates with epoxides to give A and B with a variety of values. I with B = OH or Br were converted to other "B" functionalities by using SN2 methodology. Antibacterial evaluation of compounds I with A = acetyl, isopropyl, methylthio, methylsulfinyl, methylsulfonyl, and sulfonamido and a variety of different "B" groups against Staphylococcus aureus and Enterococcus faecalis concluded that the compounds with B = aminoacyl, and particularly acetamido, were the most active of those examined in each A series, possessing MICs in the range of 0.5-4 micrograms/mL for the most active compounds described.
查看更多